Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(OP:
RLFTD
)
N/A
UNCHANGED
Last Price
Updated: 3:36 PM EST, Nov 29, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about RLFTD
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update
September 15, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics
August 30, 2023
Via
ACCESSWIRE
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE(R) in the Middle East
June 23, 2023
Via
ACCESSWIRE
RELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private Placement
June 23, 2023
Via
ACCESSWIRE
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of Shareholders
June 20, 2023
Via
ACCESSWIRE
RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement
June 16, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Executive Leadership Team Changes
December 08, 2022
Via
ACCESSWIRE
Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil)
November 07, 2022
Via
ACCESSWIRE
RELIEF THERAPEUTICS Holding SA Announces Notice of Annual General Meeting of Shareholders
May 26, 2023
Via
ACCESSWIRE
Relief Therapeutics Announces Issuance of Shares from Authorized Capital
December 13, 2022
Via
ACCESSWIRE
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival
November 21, 2022
Via
ACCESSWIRE
Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission
November 16, 2022
Via
ACCESSWIRE
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
November 14, 2022
Via
ACCESSWIRE
Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. Further Extend their Stay of Pending Litigation to Provide Additional Time for the Parties to Finalize their Litigation Settlement
November 08, 2022
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.